Menu
Menu
Expiration dates to claim credit:
19A: April 30, 2023
19B: October 31, 2023
Test your knowledge of anesthesia fundamentals!
Developed by practicing anesthesiologists, each issue of ACE includes 100 multiple choice questions (200 per annual... Read More +
The American Society of Anesthesiologists is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The American Society of Anesthesiologists designates this enduring material for a maximum of 60 AMA PRA Category 1 Credits™. For the 19A issue, up to 1 of 30 credits may be allotted to the Patient Safety CME requirement of the American Board of Anesthesiology (ABA). For the 19B issue, 0.25 of 30 credits may be allotted to the Patient Safety requirement. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit for Canadian MOC Participants: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.
For information on other accreditations, contact ASA Member Services at (847) 825-5586
You may access the course via the following links:
19A Electronic
19A Booklet
You can only access courses that you purchased or are complimentary. To access all of your courses, log into asahq.org/MyCourses. Or, via the ASAHQ.org homepage, hover over the Education & CME tab on the main menu, and click on “My Courses.”
After successfully completing this activity, the learner will be able to
Joel O. Johnson, MD, PhD
Co-Editor-in-Chief
Madison, Wisconsin
Stacy L. Jones, MD, MHA, FASA
Co-Editor-in-Chief
Little Rock, Arkansas
Anuj K. Aggarwal, MD
Stanford, California
Shamsuddin Akhtar, MD
New Haven, Connecticut
Kallol Chaudhuri, MD, PhD
Lubbock, Texas
Richard P. Dutton, MD, MBA, FASA
Dallas, Texas
Bhargavi Gali, MD
Rochester, Minnesota
Jennifer M. Hah, MD
Stanford, California
Russell K. McAllister, MD, FASA
Temple, Texas
Shobana Rajan, MD, FASA
Houston, Texas
Sara Robertson, MD, FASA
Madison, Mississippi
Kathryn Rouine-Rapp, MD
San Francisco, California
Johannes W. Steyn, MD
Nicholasville, Kentucky
Kofi B. Vandyck, MD
Oklahoma City, Oklahoma
Additional Contributors: Christopher J. Lace, MD, MBA, Denver, Colorado; Jeffrey Lu, MD, Salt Lake City, Utah
ASA Staff: Ginger Clark, Managing Editor
Resolution of Conflicts of Interest: ASA remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of ASA to eliminate all situations of potential conflict of interest, but rather to enable those who are working with ASA to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the educational activity course director/chair to ensure that such situations are properly evaluated and, if necessary, resolved. ASA educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all ASA activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities.
Ineligible companies are those not eligible to be accredited by the Accreditation Council for Continuing Medical Education because the primary business of these companies is producing, marketing, selling, reselling, or distributing health care products used by or on patients. The faculty and staff below have reported the following financial relationships with ineligible companies:
Anuj K. Aggarwal, MD
AbbVie: Stock (self)
Gilead Sciences: Stock (self)
GlaxoSmithKline: Stock (self)
Pfizer: Stock (self)
Ginger Clark
Merck: Stock (self)
Organon & Co: Stock (self)
Jennifer M. Hah, MD
Nalu Medical: Independent contractor—consultant (self)
SPR Therapeutics, Inc: Independent contractor—consultant (self)
Kofi B. Vandyck, MD
Abiomed: Stock (self)
Medtronic: Stock (self)
General Electric: Stock (self)
Johnson & Johnson Health Care Systems Inc: Stock (self)
Edwards Lifesciences: Stock (self)
Quantra QStat Study: Independent contractor—other (self)
All disclosed financial relationships have been mitigated. All other faculty, planners, and staff have reported no financial relationships with ineligible companies.
